← Leaderboards
Christiano Alves
Massachusetts General Hospital
$613,733
Attributed
$738,983
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $494.5K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$738,983 · 2
By mechanism
K01$488,483 · 1
R21$250,500 · 1
Top collaborators
- Elisabetta Morini1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Susan A Slaugenhaupt$22,094,242
- Shengdar Tsai$7,312,012
- Dadi Gao$949,484
- Sylvie Breton$16,832,550
- Xandra Owens Breakefield$30,735,276
Others in their field
Other Rising Stars on “Technology”
- Gary Mays · Axle Informatics, Llc$59,170,713
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$39,962,545
- David Annett · Information Management Services, Inc.$34,721,865
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Cyrus Wadia · Activate Global, Inc.$31,489,493
Research focus
TechnologyDependovirusProgramsSuccessExperimental StudyFamilyMutationPhenotypeSmn2 GeneSpinal Muscular AtrophyBase EditingDoseBase EditorGenome EditingIn VivoMouse ModelEfficacy EvaluationNeuromuscular DiseasesExon SkippingInfant MortalityGenesGeneticInjectionsAntisense Oligonucleotides
Grant awards (3)
A one and done therapeutic strategy to correct ELP1 splicing defect in familial dysautonomia$250,500
R21 · FY2025 · EY
Development of in Vivo Base Editing as a Genetic Treatment for Spinal Muscular Atrophy$244,025
K01 · FY2025 · NS · contact PI
Development of in Vivo Base Editing as a Genetic Treatment for Spinal Muscular Atrophy$244,458
K01 · FY2024 · NS · contact PI